More than 40% of Medicare enrollees have at least one heart condition, meaning the new Wegovy approval could greatly expand older adults' access to a drug that so far has been limited for this group.
Drugmakers, lobbying Congress to reverse Medicare's prohibition on weight-loss drugs, are also working to secure FDA approval for these drugs for kidney disease, sleep apnea, and other conditions related to obesity.
[
add
]
[
|
|
...
]